Literature DB >> 25212612

Draft Genome Sequence of Acinetobacter baumannii Strain ABBL099, a Multidrug-Resistant Clinical Outbreak Isolate with a Novel Multilocus Sequence Type.

Egon A Ozer1, Margaret A Fitzpatrick2, Alan R Hauser.   

Abstract

Acinetobacter baumannii is associated with hospital-acquired infections and can cause persistent outbreaks. Here we report the draft genome sequence of ABBL099, a multidrug-resistant clinical isolate of A. baumannii belonging to a novel sequence type and representative of clonal isolates cultured from patients at one institution over a 4-year time period.
Copyright © 2014 Ozer et al.

Entities:  

Year:  2014        PMID: 25212612      PMCID: PMC4161741          DOI: 10.1128/genomeA.00738-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii is a common cause of hospital-acquired infections, particularly pneumonia and catheter-related bloodstream infections, and often causes clonal outbreaks in critically ill patients (1–3). A. baumannii infections have been associated with high attributable mortality and increased hospital length of stay (4). Multidrug resistance is often a predictor of poor clinical outcomes in patients infected with A. baumannii (5). A. baumannii is characterized by a significant capacity for long-term persistence in hospital environments, with clonal infections recurring in patients in the same hospital or unit over the course of years (6). In this study, we determined the draft genome sequence of the A. baumannii multidrug-resistant strain ABBL099, a representative of a group of 11 clonal isolates collected between 2009 and 2012 from bloodstream infections in patients at Northwestern Memorial Hospital in Chicago, IL. Antibiotic susceptibilities were determined by Vitek2 (bioMérieux, France) (V), E tests (bioMérieux, France) (E), or disk diffusion (D). ABBL099 was found to be susceptible to ampicillin/sulbactam (V), tobramycin (V), and colistin (E) and resistant to imipenem (V), minocycline (D), doxycycline (D), amikacin (V), ciprofloxacin (V), and piperacillin/tazobactam (D). The tigecycline MIC was 8 mg/L (E). Whole-genome shotgun sequencing was performed on the Illumina HiSeq 2000 platform, generating 8,769,372 pairs of 101-bp paired-end reads with 250-bp inserts. Reads were randomly down sampled to yield approximately 150× genome coverage (2,970,296 read pairs) and de novo assembled using Ray v. 2.3.0 (7), generating 172 total contigs. The assembly was filtered for contigs larger than 200 bp, leaving 155 contigs with a total length of 3,917,723 bp, an N50 of 53,298 bp, and an average contig length of 25,276 bp. The overall G+C content was 38.9%. Sequence annotation was performed using Prokka v. 1.9 (8), yielding 3,686 predicted protein-coding genes with an average gene length of 926 bp and a total length of 3,413,736 bp, covering 87.14% of the draft genome. In addition, 59 tRNA genes were identified and annotated, as well as 9 complete or partial rRNA gene annotations. ABBL099 was confirmed to belong to the species A. baumannii both through alignment of sequencing reads to the Silva 16S rRNA gene sequence database (9) as well as through evaluation of the rpoB gene sequence in the assembled contigs (10). The allele sequences of the cpn60, fusA, gltA, pyrG, recA, rplB, and rpoB genes were identified in the Institut Pasteur A. baumannii multilocus sequence typing (MLST) database (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html) and found to represent a previously unreported sequence type. We have since submitted the sequence type of ABBL099 to the Institut Pasteur database as ST 499.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number JPDG00000000. The version described in this paper is version JPDG01000000.
  10 in total

1.  Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies.

Authors:  Sébastien Boisvert; François Laviolette; Jacques Corbeil
Journal:  J Comput Biol       Date:  2010-10-20       Impact factor: 1.479

2.  A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.

Authors:  Wang-Huei Sheng; Chun-Hsing Liao; Tsai-Ling Lauderdale; Wen-Chien Ko; Yao-Shen Chen; Jien-Wei Liu; Yeu-Jun Lau; Li-Hsin Wang; Ke-Sun Liu; Tung-Yuan Tsai; San-Yi Lin; Meng-Shiuan Hsu; Le-Yin Hsu; Shan-Chwen Chang
Journal:  Int J Infect Dis       Date:  2010-06-19       Impact factor: 3.623

3.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

4.  Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period.

Authors:  Antonietta Lambiase; Ornella Piazza; Fabio Rossano; Mariassunta Del Pezzo; Rosalba Tufano; Maria Rosaria Catania
Journal:  New Microbiol       Date:  2012-03-31       Impact factor: 2.479

5.  Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.

Authors:  L Silvia Munoz-Price; Teresa Zembower; Sudhir Penugonda; Paul Schreckenberger; Mary Alice Lavin; Sharon Welbel; Dana Vais; Mirza Baig; Sunita Mohapatra; John P Quinn; Robert A Weinstein
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 7.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

8.  Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species.

Authors:  Bernard La Scola; Vijay A K B Gundi; Atieh Khamis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 9.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools.

Authors:  Christian Quast; Elmar Pruesse; Pelin Yilmaz; Jan Gerken; Timmy Schweer; Pablo Yarza; Jörg Peplies; Frank Oliver Glöckner
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

  10 in total
  1 in total

1.  Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance.

Authors:  Alina Iovleva; Mustapha M Mustapha; Marissa P Griffith; Lauren Komarow; Courtney Luterbach; Daniel R Evans; Eric Cober; Sandra S Richter; Kirsten Rydell; Cesar A Arias; Jesse T Jacob; Robert A Salata; Michael J Satlin; Darren Wong; Robert A Bonomo; David van Duin; Vaughn S Cooper; Daria Van Tyne; Yohei Doi
Journal:  mBio       Date:  2022-03-21       Impact factor: 7.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.